The company has significantly advanced this progress of an new therapy for ATTR-CM, leveraging Attruby. Preliminary clinical data reveals potential improvements for those diagnosed with this serious disease. This https://bridgebio518866.blogpayz.com/42410306/bridgebio-advances-amyloidosis-therapy-with-the-drug